These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2123536)

  • 1. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for evaluating the protective activity of intravenous immunoglobulins for neonatal pathogens: entanglement or encouragement?
    Baker CJ; Edwards MS
    Pediatrics; 1990 Dec; 86(6):995-7. PubMed ID: 2123537
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
    Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
    Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies.
    Fischer GW; Hemming VG; Hunter KW; Gloser H; Bachmayer H; Von Pilar CE; Helting T; Weisman LE; Wilson SR; Baron PA
    Pediatr Infect Dis; 1986; 5(3 Suppl):S171-5. PubMed ID: 3520501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyvalent group B streptococcal immune globulin for intravenous administration: overview.
    Fischer GW; Hemming VG; Gloser HP; Bachmayer H; von Pilar CE; Wilson SR; Baron PA
    Rev Infect Dis; 1990; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
    Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
    J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
    Bortolussi R; Fischer GW
    Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
    Weisman LE; Anthony BF; Hemming VG; Fischer GW
    J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
    Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
    J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
    Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
    J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of specific antibody in neonatal bacterial infections: an overview.
    Anthony BF
    Pediatr Infect Dis; 1986; 5(3 Suppl):S164-7. PubMed ID: 3520499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB; Edwards MS; Baker CJ
    J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of antibacterial and antitoxic activity of normal human immunoglobulin for intravenous use (IVIG)].
    Bucholc B; Banach W; Wysokińska T; Cieślik A; Chodorowska M
    Med Dosw Mikrobiol; 1996; 48(1-2):87-94. PubMed ID: 8926773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
    Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
    J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci.
    Hill HR; Gonzales LA; Knappe WA; Fischer GW; Kelsey DK; Raff HV
    J Infect Dis; 1991 Apr; 163(4):792-8. PubMed ID: 2010632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of intravenous immune globulin for group B streptococcal infection.
    Baker CJ; Noya FJ
    Rev Infect Dis; 1990; 12 Suppl 4():S476-82. PubMed ID: 2194272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review.
    Fischer GW; Weisman LE; Hemming VG
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S92-7. PubMed ID: 1728993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity.
    Heiman HS; Weisman LE
    Vet Immunol Immunopathol; 1990 Jan; 24(1):79-89. PubMed ID: 2180204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.